stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Debt to equity
ICON PLC's debt to equity at the end of the quarter to 30 September 2026 was 0.4×, up 0.0× from fiscal 2025 (0.4×). Over the past ten years it has ranged from 0.2× (fiscal 2020) to 0.7× (fiscal 2021); the current reading is higher than 64% of that period. That is above the Diagnostics & Research industry median of 0.0× and above the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.4× | 1.98% |
| FY2024 | 0.4× | (11.18%) |
| FY2023 | 0.4× | (25.40%) |
| FY2022 | 0.5× | (18.73%) |
| FY2021 | 0.7× | 234.77% |
| FY2020 | 0.2× | (21.79%) |
| FY2019 | 0.3× | (0.19%) |
| FY2018 | 0.3× | (11.95%) |
| FY2017 | 0.3× | (20.56%) |
| FY2016 | 0.4× | (19.22%) |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.4× | 2.41% |
| Jun 2026 | 0.4× | (1.01%) |
| Mar 2026 | 0.4× | (1.32%) |
| Dec 2025 | 0.4× | 1.37% |
| 43 more quarters | Free account |
Against its own ten years
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| GH Guardant Health, Inc. compare | −5.4× |
| MEDP Medpace Holdings, Inc. compare | 0.0× |
| RVTY Revvity Inc. compare | 0.4× |
| ICLR ICON PLC | 0.4× |
| QGEN QIAGEN N.V. compare | 0.5× |
| ILMN Illumina, Inc. compare | 0.6× |
| LH Labcorp Holdings Inc. compare | 0.6× |
| DGX Quest Diagnostics Incorporated compare | 0.7× |
| CRL Charles River Laboratories International, Inc. compare | 0.8× |
| Diagnostics & Research industry median | 0.0× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement